Healthcare · Pharmaceutical expenditure
Japan's pharmaceutical expenditure reached 2.30 % GDP of GDP in 2026, ranking 7th out of 197 countries. This high level is driven by the rapidly aging population — over 29% of Japanese are aged 65+ — and growing demand for prescription drugs, especially for chronic conditions. Japan hosts the world's third-largest pharmaceutical market, with giants like Takeda and Daiichi Sankyo leading innovation. High prices for patented drugs and widespread prescribing practices further elevate spending.
Data for 2026 · unit: % GDP
Position
#7 / 197
Japan world ranking
Country position on the scale from last to first place for this indicator.
JP
#7
#197#1
Trend
Change over time
Change in indicator over the available period.
1.50
1990
1.80
2000
2.00
2010
2.20
2020
2.30
2026
Values — % GDP
Comparison
Top countries by Pharmaceutical expenditure
Where Japan stands in the world ranking.
1
USUSA
2.65
2
NLNetherlands
2.60
3
NONorway
2.50
4
MCMonaco
2.40
4
NZNew Zealand
2.40
6
DEGermany
2.35
7
JPJapan
2.30
8
FRFrance
2.25
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Pharmaceutical expenditure in Japan — how much?
Based on 2026 data — 2.30 % GDP. This is rank #7 out of 197 countries.
What is Japan's rank by Pharmaceutical expenditure?
Japan ranks #7 out of 197 countries in the world ranking by «Pharmaceutical expenditure».
How has Pharmaceutical expenditure changed in Japan?
Over the available period the indicator changed from 1.50 to 2.30 % GDP.